Page last updated: 2024-09-05

cucurbitacin r and Colonic Neoplasms

cucurbitacin r has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Augenlicht, L; Escandell, JM; Kaler, P; Klampfer, L; Recio, MC; Ríos, JL; Sasazuki, T; Shirasawa, S	1

Other Studies

1 other study(ies) available for cucurbitacin r and Colonic Neoplasms

Article	Year
Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21. Biochemical pharmacology, 2008, Jul-15, Volume: 76, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Triterpenes; Tumor Suppressor Protein p53	2008

Article

Year

Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.

Biochemical pharmacology, 2008, Jul-15, Volume: 76, Issue:2

Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Triterpenes; Tumor Suppressor Protein p53

2008